Literature DB >> 20625671

Evaluation of the exhaled carbon monoxide levels in smokers with COPD.

Gustavo Chatkin1, José Miguel Chatkin, Gabriel Aued, Guilherme Oliveira Petersen, Edna Thais Jeremias, Flávia Valladão Thiesen.   

Abstract

OBJECTIVE: To measure exhaled carbon monoxide (COex) levels in smokers with and without COPD.
METHODS: Smokers treated at outpatient clinics of São Lucas Hospital in the city of Porto Alegre, Brazil, between September of 2007 and March of 2009 were invited to participate in this study. The participants completed a questionnaire regarding demographic and epidemiologic characteristics and were submitted to spirometry, as well as to determination of COex and urinary cotinine levels. The participants were divided into two groups: those with COPD and those without COPD.
RESULTS: The study involved 294 smokers, of whom 174 (59.18%) had been diagnosed with COPD. All of the participants presented with urinary cotinine levels > 50 ng/mL. Smokers with COPD presented significantly higher median values for age and pack-years than did those without COPD (p < 0.001 and p = 0.026, respectively). No other statistically significant differences were found. When adjusted for gender, age at smoking onset, number of cigarettes/day and urinary cotinine level, the mean values of COex were higher, but not statistically so, in the COPD group than in the non-COPD group (17.8 +/- 0.6 ppm and 16.6 +/- 0.7 ppm, respectively; p = 0.200). The differences remained nonsignificant when plotted logarithmically. A wide dispersion of COex values was found when the participants were classified by FEV1 level (r = -0.06; p = 0.53) or by Global Initiative for Chronic Obstructive Lung Disease classification (r = 0.08; p = 0.34). The proportions of false-negative results for smoking were 18.4% and 6.7%, respectively, in the COPD and non-COPD groups (p = 0.007).
CONCLUSIONS: Since COex values did not differ significantly between smokers with COPD and those without, there seem to be no major contraindications to their use in smokers with COPD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625671     DOI: 10.1590/s1806-37132010000300011

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  8 in total

1.  Relevance of anamnesis and of biomarkers in the assessment of smoking among patients with airway disease.

Authors:  Ubiratan de Paula Santos
Journal:  J Bras Pneumol       Date:  2015 Mar-Apr       Impact factor: 2.624

2.  Prevalence and incidence of chronic obstructive pulmonary disease in Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Juan J Olortegui-Rodriguez; David R Soriano-Moreno; Alejandro Benites-Bullón; Pilar P Pelayo-Luis; Jorge Huaringa-Marcelo
Journal:  BMC Pulm Med       Date:  2022-07-16       Impact factor: 3.320

Review 3.  A survey of recently published cardiovascular, hematological and pneumological original articles in the Brazilian scientific press.

Authors:  Kavita Kirankumar Patel; Bruno Caramelli; Ariane Gomes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Levels of exhaled carbon monoxide measured during an intervention program predict 1-year smoking cessation: a retrospective observational cohort study.

Authors:  Huei-Guan Shie; Sheng-Wei Pan; Wen-Kuang Yu; Wei-Chih Chen; Li-Ing Ho; Hsin-Kuo Ko
Journal:  NPJ Prim Care Respir Med       Date:  2017-10-16       Impact factor: 2.871

Review 5.  Airway disease: similarities and differences between asthma, COPD and bronchiectasis.

Authors:  Rodrigo Athanazio
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

6.  Reversion of AHRR Demethylation Is a Quantitative Biomarker of Smoking Cessation.

Authors:  Robert Philibert; Nancy Hollenbeck; Eleanor Andersen; Shyheme McElroy; Scott Wilson; Kyra Vercande; Steven R H Beach; Terry Osborn; Meg Gerrard; Frederick X Gibbons; Kai Wang
Journal:  Front Psychiatry       Date:  2016-04-06       Impact factor: 4.157

7.  Pressure Ulcer Risk Evaluation in Critical Patients: Clinical and Social Characteristics.

Authors:  Mônica Suêla de Azevedo Macena; Rayanne Suely da Costa Silva; Maria Isabel Da Conceição Dias Fernandes; Ana Beatriz de Almeida Medeiros; Kadyjina Daiane Batista Lúcio; Ana Luisa Brandão de Carvalho Lira
Journal:  Open Nurs J       Date:  2017-07-28

8.  Correlation of exhaled carbon monoxide level with disease severity in chronic obstruction pulmonary disease.

Authors:  Md Arshad Ejazi; Mohammad Shameem; Rakesh Bhargava; Zuber Ahmad; Jamal Akhtar; Nafeees A Khan; Md Mazhar Alam; Md Arif Alam; C G Adil Wafi
Journal:  Lung India       Date:  2018 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.